Patents/Assignees

NATIONAL CANCER CENTER

56 patents in portfolio

US11897954utility2024
Anti-tspan8/anti-cd3 Bispecific Antibody and Anti-tspan8 Antibody
0 cites
US11869193utility2024
Computer-readable Recoding Medium Having Stored Therein Estimation Processing Program, Estimation Processing Method and Information Processing Apparatus
0 cites
US11859255utility2024
Breast Cancer Detection Kit or Device, and Detection Method
0 cites
US11859256utility2024
Stomach Cancer Detection Kit or Device, and Detection Method
0 cites
US11827941utility2023
Liver Cancer Detection Kit or Device, and Detection Method
0 cites
US11813332utility2023
Photosensitizer-peptide Conjugate Comprising Degradable Linker, and Composition for Photodynamic Diagnosis or Treatment Comprising Same
0 cites
US11788150utility2023
Pancreatic Cancer Detection Kit or Device, and Detection Method
0 cites
US11761046utility2023
Biliary Tract Cancer Detection Kit or Device, and Detection Method
0 cites
US11732307utility2023
Kit, Device, and Method for Detecting Bladder Cancer
0 cites
US11733250utility2023
Method and Kit for the Detection of Pancreatic Dysfunction
0 cites
US11717556utility2023
Stemness-suppressing Composition Comprising OCT4 Function-inhibiting Peptide
0 cites
US11676361utility2023
Computer-readable Recording Medium Having Stored Therein Training Program, Training Method, and Information Processing Apparatus
0 cites
US11634778utility2023
Kit, Device, and Method for Detecting Lung Cancer
0 cites
US11553829utility2023
Information Processing Apparatus, Control Method and Program
0 cites
US11542558utility2023
Esophageal Cancer Detection Kit or Device, and Detection Method
0 cites
US8343943utility2013
Cancer Sensitizer Comprising Glucosamine, Glucosamine Derivatives or Salts Thereof
0 cites

← PreviousPage 3 of 3